NDI Healthcare Fund Joins $5M Series A For SPR Therapeutics

January 9, 2013

Neurodevice firm SPR™ Therapeutics has raised $5 million in Series A financing from NDI Healthcare Fund, Public Square Partners, and individual investors. These funds will be used to commercialize pain therapies utilizing SPR’s proprietary peripheral nerve stimulation technology.

 

Read Full Article Here: http://www.pehub.com/180184/neurodevice-co-spr-therapeutics-raises-series-a/

Posted in
Health/Biotech, Venture Capital
and tagged with
Neurodevice
.

Why Open a Browser, get citybizlist in your InBox.